1. Home
  2. BEAM vs MSGE Comparison

BEAM vs MSGE Comparison

Compare BEAM & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • MSGE
  • Stock Information
  • Founded
  • BEAM 2017
  • MSGE 2020
  • Country
  • BEAM United States
  • MSGE United States
  • Employees
  • BEAM N/A
  • MSGE N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • MSGE Services-Misc. Amusement & Recreation
  • Sector
  • BEAM Health Care
  • MSGE Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • MSGE Nasdaq
  • Market Cap
  • BEAM 1.9B
  • MSGE 1.9B
  • IPO Year
  • BEAM 2020
  • MSGE N/A
  • Fundamental
  • Price
  • BEAM $22.93
  • MSGE $40.92
  • Analyst Decision
  • BEAM Buy
  • MSGE Buy
  • Analyst Count
  • BEAM 10
  • MSGE 5
  • Target Price
  • BEAM $47.00
  • MSGE $44.20
  • AVG Volume (30 Days)
  • BEAM 998.5K
  • MSGE 270.4K
  • Earning Date
  • BEAM 11-05-2024
  • MSGE 11-12-2024
  • Dividend Yield
  • BEAM N/A
  • MSGE N/A
  • EPS Growth
  • BEAM N/A
  • MSGE 102.04
  • EPS
  • BEAM N/A
  • MSGE 2.97
  • Revenue
  • BEAM $352,567,000.00
  • MSGE $959,265,000.00
  • Revenue This Year
  • BEAM N/A
  • MSGE $4.45
  • Revenue Next Year
  • BEAM $8.94
  • MSGE $5.29
  • P/E Ratio
  • BEAM N/A
  • MSGE $13.78
  • Revenue Growth
  • BEAM 339.83
  • MSGE 12.66
  • 52 Week Low
  • BEAM $18.85
  • MSGE $27.55
  • 52 Week High
  • BEAM $49.50
  • MSGE $44.05
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 46.94
  • MSGE 40.15
  • Support Level
  • BEAM $21.79
  • MSGE $41.18
  • Resistance Level
  • BEAM $22.70
  • MSGE $42.89
  • Average True Range (ATR)
  • BEAM 1.09
  • MSGE 0.86
  • MACD
  • BEAM -0.07
  • MSGE -0.22
  • Stochastic Oscillator
  • BEAM 28.56
  • MSGE 14.08

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: